APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hypertension Medications

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hypertension Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174001080322 December 2025193 pages

Choose your research edition.

Industry ResearchHypertension Medications Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Hypertension Medications Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Hypertension Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hypertension Medications Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Hypertension Medications Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Hypertension Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Hypertension Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hypertension Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hypertension Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hypertension Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hypertension Medications include Chengdu Easton Biopharmaceuticals, CSPC Pharmaceutical Group, Shanghai Shyndec Pharmaceutical, Sanofi, Qingdao Huanghai Pharmaceutical, Novartis, Merck, Jiangsu Jibeier Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Hypertension Medications market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hypertension Medications and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hypertension Medications revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Hypertension Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Hypertension Medications Segment by Company

Chengdu Easton Biopharmaceuticals

CSPC Pharmaceutical Group

Shanghai Shyndec Pharmaceutical

Sanofi

Qingdao Huanghai Pharmaceutical

Novartis

Merck

Jiangsu Jibeier Pharmaceutical

Pfizer

CR Double-Crane

Huahai Pharmaceutical

Jiangsu Hengrui Medicine

Tianjin Pharmaceutical Da Ren Tang Group

Boehringer Ingelheim

Bayer

AstraZeneca

Lupin Pharmaceuticals

Hypertension Medications Segment by Type

Angiotensin II Receptor Blockers

Diuretics

Calcium Channel Blockers

Compound Drugs

Beta Blockers

ACE Inhibitors

Others

Hypertension Medications Segment by Application

Hospital

Clinic

Others

Hypertension Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hypertension Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hypertension Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hypertension Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Hypertension Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hypertension Medications industry.

Chapter 3: Detailed analysis of Hypertension Medications companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hypertension Medicationsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hypertension Medications Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Angiotensin II Receptor Blockers Table 3. Key Players of Diuretics Table 4. Key Players of Calcium Channel Blockers Table 3. Key Players of Compound Drugs Table 4. Key Players of Beta Blockers Table 5. Key Players of ACE Inhibitors Table 6. Key Players of Others Table 7. Global Hypertension Medications Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 8. Key Players of Hospital Table 9. Key Players of Clinic Table 10. Key Players of Others Table 11. Global Hypertension Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Hypertension Medications Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Hypertension Medications Market Share by Region (2021-2026) Table 14. Global Hypertension Medications Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Hypertension Medications Market Share by Region (2027-2032) Table 16. Hypertension Medications Industry Trends Table 17. Hypertension Medications Industry Drivers Table 18. Hypertension Medications Industry Opportunities and Challenges Table 19. Hypertension Medications Industry Restraints Table 20. Global Hypertension Medications Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Hypertension Medications Revenue Market Share by Company (2021-2026) Table 22. Global Hypertension Medications Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Hypertension Medications Key Company Head Office and Area Served Table 24. Global Hypertension Medications Company, Product Type & Application Table 25. Global Hypertension Medications Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Hypertension Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Hypertension Medications Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Hypertension Medications Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Hypertension Medications Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Hypertension Medications Revenue Market Share by Type (2021-2026) Table 32. Global Hypertension Medications Revenue Market Share by Type (2027-2032) Table 33. Global Hypertension Medications Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Hypertension Medications Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Hypertension Medications Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Hypertension Medications Revenue Market Share by Application (2021-2026) Table 37. Global Hypertension Medications Revenue Market Share by Application (2027-2032) Table 38. Chengdu Easton Biopharmaceuticals Company Information Table 39. Chengdu Easton Biopharmaceuticals Business Overview Table 40. Chengdu Easton Biopharmaceuticals Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Chengdu Easton Biopharmaceuticals Hypertension Medications Product Portfolio Table 42. Chengdu Easton Biopharmaceuticals Recent Development Table 43. CSPC Pharmaceutical Group Company Information Table 44. CSPC Pharmaceutical Group Business Overview Table 45. CSPC Pharmaceutical Group Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. CSPC Pharmaceutical Group Hypertension Medications Product Portfolio Table 47. CSPC Pharmaceutical Group Recent Development Table 48. Shanghai Shyndec Pharmaceutical Company Information Table 49. Shanghai Shyndec Pharmaceutical Business Overview Table 50. Shanghai Shyndec Pharmaceutical Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Shanghai Shyndec Pharmaceutical Hypertension Medications Product Portfolio Table 52. Shanghai Shyndec Pharmaceutical Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Sanofi Hypertension Medications Product Portfolio Table 57. Sanofi Recent Development Table 58. Qingdao Huanghai Pharmaceutical Company Information Table 59. Qingdao Huanghai Pharmaceutical Business Overview Table 60. Qingdao Huanghai Pharmaceutical Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Qingdao Huanghai Pharmaceutical Hypertension Medications Product Portfolio Table 62. Qingdao Huanghai Pharmaceutical Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Novartis Hypertension Medications Product Portfolio Table 67. Novartis Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Merck Hypertension Medications Product Portfolio Table 72. Merck Recent Development Table 73. Jiangsu Jibeier Pharmaceutical Company Information Table 74. Jiangsu Jibeier Pharmaceutical Business Overview Table 75. Jiangsu Jibeier Pharmaceutical Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Jiangsu Jibeier Pharmaceutical Hypertension Medications Product Portfolio Table 77. Jiangsu Jibeier Pharmaceutical Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Pfizer Hypertension Medications Product Portfolio Table 82. Pfizer Recent Development Table 83. CR Double-Crane Company Information Table 84. CR Double-Crane Business Overview Table 85. CR Double-Crane Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. CR Double-Crane Hypertension Medications Product Portfolio Table 87. CR Double-Crane Recent Development Table 88. Huahai Pharmaceutical Company Information Table 89. Huahai Pharmaceutical Business Overview Table 90. Huahai Pharmaceutical Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Huahai Pharmaceutical Hypertension Medications Product Portfolio Table 92. Huahai Pharmaceutical Recent Development Table 93. Jiangsu Hengrui Medicine Company Information Table 94. Jiangsu Hengrui Medicine Business Overview Table 95. Jiangsu Hengrui Medicine Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Jiangsu Hengrui Medicine Hypertension Medications Product Portfolio Table 97. Jiangsu Hengrui Medicine Recent Development Table 98. Tianjin Pharmaceutical Da Ren Tang Group Company Information Table 99. Tianjin Pharmaceutical Da Ren Tang Group Business Overview Table 100. Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Product Portfolio Table 102. Tianjin Pharmaceutical Da Ren Tang Group Recent Development Table 103. Boehringer Ingelheim Company Information Table 104. Boehringer Ingelheim Business Overview Table 105. Boehringer Ingelheim Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. Boehringer Ingelheim Hypertension Medications Product Portfolio Table 107. Boehringer Ingelheim Recent Development Table 108. Bayer Company Information Table 109. Bayer Business Overview Table 110. Bayer Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. Bayer Hypertension Medications Product Portfolio Table 112. Bayer Recent Development Table 113. AstraZeneca Company Information Table 114. AstraZeneca Business Overview Table 115. AstraZeneca Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 116. AstraZeneca Hypertension Medications Product Portfolio Table 117. AstraZeneca Recent Development Table 118. Lupin Pharmaceuticals Company Information Table 119. Lupin Pharmaceuticals Business Overview Table 120. Lupin Pharmaceuticals Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026) Table 121. Lupin Pharmaceuticals Hypertension Medications Product Portfolio Table 122. Lupin Pharmaceuticals Recent Development Table 123. North America Hypertension Medications Market Size by Type (2021-2026) & (US$ Million) Table 124. North America Hypertension Medications Market Size by Type (2027-2032) & (US$ Million) Table 125. North America Hypertension Medications Market Size by Application (2021-2026) & (US$ Million) Table 126. North America Hypertension Medications Market Size by Application (2027-2032) & (US$ Million) Table 127. North America Hypertension Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Hypertension Medications Market Size by Country (2021-2026) Table 129. North America Hypertension Medications Market Size by Country (2027-2032) Table 130. Europe Hypertension Medications Market Size by Type (2021-2026) & (US$ Million) Table 131. Europe Hypertension Medications Market Size by Type (2027-2032) & (US$ Million) Table 132. Europe Hypertension Medications Market Size by Application (2021-2026) & (US$ Million) Table 133. Europe Hypertension Medications Market Size by Application (2027-2032) & (US$ Million) Table 134. Europe Hypertension Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe Hypertension Medications Market Size by Country (2021-2026) Table 136. Europe Hypertension Medications Market Size by Country (2027-2032) Table 137. China Hypertension Medications Market Size by Type (2021-2026) & (US$ Million) Table 138. China Hypertension Medications Market Size by Type (2027-2032) & (US$ Million) Table 139. China Hypertension Medications Market Size by Application (2021-2026) & (US$ Million) Table 140. China Hypertension Medications Market Size by Application (2027-2032) & (US$ Million) Table 141. Asia Hypertension Medications Market Size by Type (2021-2026) & (US$ Million) Table 142. Asia Hypertension Medications Market Size by Type (2027-2032) & (US$ Million) Table 143. Asia Hypertension Medications Market Size by Application (2021-2026) & (US$ Million) Table 144. Asia Hypertension Medications Market Size by Application (2027-2032) & (US$ Million) Table 145. Asia Hypertension Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Hypertension Medications Market Size by Country (2021-2026) Table 147. Asia Hypertension Medications Market Size by Country (2027-2032) Table 148. South America, Middle East & Africa Hypertension Medications Market Size by Type (2021-2026) & (US$ Million) Table 149. South America, Middle East & Africa Hypertension Medications Market Size by Type (2027-2032) & (US$ Million) Table 150. South America, Middle East & Africa Hypertension Medications Market Size by Application (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa Hypertension Medications Market Size by Application (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa Hypertension Medications Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. South America, Middle East & Africa Hypertension Medications Market Size by Country (2021-2026) Table 154. South America, Middle East & Africa Hypertension Medications Market Size by Country (2027-2032) Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Hypertension Medications Product Image Figure 2. Global Hypertension Medications Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Hypertension Medications Market Share by Type: 2025 VS 2032 Figure 4. Angiotensin II Receptor Blockers Image Figure 5. Diuretics Image Figure 6. Calcium Channel Blockers Image Figure 7. Compound Drugs Image Figure 8. Beta Blockers Image Figure 9. ACE Inhibitors Image Figure 10. Others Image Figure 11. Global Hypertension Medications Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 12. Global Hypertension Medications Market Share by Application: 2025 VS 2032 Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Others Image Figure 16. Global Hypertension Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 18. Global Hypertension Medications Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Hypertension Medications Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Hypertension Medications Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Hypertension Medications Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Hypertension Medications Revenue Market Share by Type (2021-2032) Figure 25. Global Hypertension Medications Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Hypertension Medications Revenue Market Share by Application (2021-2032) Figure 27. North America Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 28. North America Hypertension Medications Market Share by Type (2021-2032) Figure 29. North America Hypertension Medications Market Share by Application (2021-2032) Figure 30. North America Hypertension Medications Market Share by Country (2021-2032) Figure 31. United States Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 32. Canada Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 34. Europe Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 35. Europe Hypertension Medications Market Share by Type (2021-2032) Figure 36. Europe Hypertension Medications Market Share by Application (2021-2032) Figure 37. Europe Hypertension Medications Market Share by Country (2021-2032) Figure 38. Germany Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 39. France Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 41. Italy Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 42. Russia Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 44. China Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 45. China Hypertension Medications Market Share by Type (2021-2032) Figure 46. China Hypertension Medications Market Share by Application (2021-2032) Figure 47. Asia Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 48. Asia Hypertension Medications Market Share by Type (2021-2032) Figure 49. Asia Hypertension Medications Market Share by Application (2021-2032) Figure 50. Asia Hypertension Medications Market Share by Country (2021-2032) Figure 51. Japan Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 55. India Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 56. Australia Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Hypertension Medications Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Hypertension Medications Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Hypertension Medications Market Share by Country (2021-2032) Figure 61. Brazil Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 66. UAE Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 68. Chile Hypertension Medications Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Angiotensin II Receptor Blockers
  • Diuretics
  • Calcium Channel Blockers
  • Compound Drugs
  • Beta Blockers
  • ACE Inhibitors
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chengdu Easton Biopharmaceuticals
  • CSPC Pharmaceutical Group
  • Shanghai Shyndec Pharmaceutical
  • Sanofi
  • Qingdao Huanghai Pharmaceutical
  • Novartis
  • Merck
  • Jiangsu Jibeier Pharmaceutical
  • Pfizer
  • CR Double-Crane
  • Huahai Pharmaceutical
  • Jiangsu Hengrui Medicine
  • Tianjin Pharmaceutical Da Ren Tang Group
  • Boehringer Ingelheim
  • Bayer
  • AstraZeneca
  • Lupin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Hypertension Medications Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Angiotensin II Receptor Blockers
  5. 1.2.3 Diuretics
  6. 1.2.4 Calcium Channel Blockers
  7. 1.2.5 Compound Drugs
  8. 1.2.6 Beta Blockers
  9. 1.2.7 ACE Inhibitors
  10. 1.2.8 Others
  11. 1.3 Market Analysis by Application
  12. 1.3.1 Global Hypertension Medications Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  13. 1.3.2 Hospital
  14. 1.3.3 Clinic
  15. 1.3.4 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Hypertension Medications Growth Trends by Region
  18. 1.5.1 Global Hypertension Medications Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Hypertension Medications Market Size by Region (2021-2026)
  20. 1.5.3 Hypertension Medications Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Hypertension Medications Market Dynamics
  1. 2.1 Hypertension Medications Industry Trends
  2. 2.2 Hypertension Medications Industry Drivers
  3. 2.3 Hypertension Medications Industry Opportunities and Challenges
  4. 2.4 Hypertension Medications Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Hypertension Medications Revenue by Company (2021-2026)
  2. 3.2 Global Hypertension Medications Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Hypertension Medications Key Company Head office and Area Served
  4. 3.4 Global Hypertension Medications Company, Product Type & Application
  5. 3.5 Global Hypertension Medications Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Hypertension Medications Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Hypertension Medications Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Hypertension Medications Tier 1, Tier 2, and Tier 3
4 Hypertension Medications Market by Type
  1. 4.1 Global Hypertension Medications Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Hypertension Medications Market Size by Type (2021-2032)
  3. 4.3 Global Hypertension Medications Market Size Share by Type (2021-2032)
5 Hypertension Medications Market by Application
  1. 5.1 Global Hypertension Medications Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Hypertension Medications Market Size by Application (2021-2032)
  3. 5.3 Global Hypertension Medications Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Chengdu Easton Biopharmaceuticals
  2. 6.1.1 Chengdu Easton Biopharmaceuticals Company Information
  3. 6.1.2 Chengdu Easton Biopharmaceuticals Business Overview
  4. 6.1.3 Chengdu Easton Biopharmaceuticals Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Chengdu Easton Biopharmaceuticals Hypertension Medications Product Portfolio
  6. 6.1.5 Chengdu Easton Biopharmaceuticals Recent Developments
  7. 6.2 CSPC Pharmaceutical Group
  8. 6.2.1 CSPC Pharmaceutical Group Company Information
  9. 6.2.2 CSPC Pharmaceutical Group Business Overview
  10. 6.2.3 CSPC Pharmaceutical Group Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 CSPC Pharmaceutical Group Hypertension Medications Product Portfolio
  12. 6.2.5 CSPC Pharmaceutical Group Recent Developments
  13. 6.3 Shanghai Shyndec Pharmaceutical
  14. 6.3.1 Shanghai Shyndec Pharmaceutical Company Information
  15. 6.3.2 Shanghai Shyndec Pharmaceutical Business Overview
  16. 6.3.3 Shanghai Shyndec Pharmaceutical Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Shanghai Shyndec Pharmaceutical Hypertension Medications Product Portfolio
  18. 6.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sanofi Hypertension Medications Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Qingdao Huanghai Pharmaceutical
  26. 6.5.1 Qingdao Huanghai Pharmaceutical Company Information
  27. 6.5.2 Qingdao Huanghai Pharmaceutical Business Overview
  28. 6.5.3 Qingdao Huanghai Pharmaceutical Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Qingdao Huanghai Pharmaceutical Hypertension Medications Product Portfolio
  30. 6.5.5 Qingdao Huanghai Pharmaceutical Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Novartis Hypertension Medications Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Merck Hypertension Medications Product Portfolio
  42. 6.7.5 Merck Recent Developments
  43. 6.8 Jiangsu Jibeier Pharmaceutical
  44. 6.8.1 Jiangsu Jibeier Pharmaceutical Company Information
  45. 6.8.2 Jiangsu Jibeier Pharmaceutical Business Overview
  46. 6.8.3 Jiangsu Jibeier Pharmaceutical Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Jiangsu Jibeier Pharmaceutical Hypertension Medications Product Portfolio
  48. 6.8.5 Jiangsu Jibeier Pharmaceutical Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pfizer Hypertension Medications Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 CR Double-Crane
  56. 6.10.1 CR Double-Crane Company Information
  57. 6.10.2 CR Double-Crane Business Overview
  58. 6.10.3 CR Double-Crane Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 CR Double-Crane Hypertension Medications Product Portfolio
  60. 6.10.5 CR Double-Crane Recent Developments
  61. 6.11 Huahai Pharmaceutical
  62. 6.11.1 Huahai Pharmaceutical Company Information
  63. 6.11.2 Huahai Pharmaceutical Business Overview
  64. 6.11.3 Huahai Pharmaceutical Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Huahai Pharmaceutical Hypertension Medications Product Portfolio
  66. 6.11.5 Huahai Pharmaceutical Recent Developments
  67. 6.12 Jiangsu Hengrui Medicine
  68. 6.12.1 Jiangsu Hengrui Medicine Company Information
  69. 6.12.2 Jiangsu Hengrui Medicine Business Overview
  70. 6.12.3 Jiangsu Hengrui Medicine Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Jiangsu Hengrui Medicine Hypertension Medications Product Portfolio
  72. 6.12.5 Jiangsu Hengrui Medicine Recent Developments
  73. 6.13 Tianjin Pharmaceutical Da Ren Tang Group
  74. 6.13.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
  75. 6.13.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview
  76. 6.13.3 Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Tianjin Pharmaceutical Da Ren Tang Group Hypertension Medications Product Portfolio
  78. 6.13.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
  79. 6.14 Boehringer Ingelheim
  80. 6.14.1 Boehringer Ingelheim Company Information
  81. 6.14.2 Boehringer Ingelheim Business Overview
  82. 6.14.3 Boehringer Ingelheim Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Boehringer Ingelheim Hypertension Medications Product Portfolio
  84. 6.14.5 Boehringer Ingelheim Recent Developments
  85. 6.15 Bayer
  86. 6.15.1 Bayer Company Information
  87. 6.15.2 Bayer Business Overview
  88. 6.15.3 Bayer Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Bayer Hypertension Medications Product Portfolio
  90. 6.15.5 Bayer Recent Developments
  91. 6.16 AstraZeneca
  92. 6.16.1 AstraZeneca Company Information
  93. 6.16.2 AstraZeneca Business Overview
  94. 6.16.3 AstraZeneca Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 AstraZeneca Hypertension Medications Product Portfolio
  96. 6.16.5 AstraZeneca Recent Developments
  97. 6.17 Lupin Pharmaceuticals
  98. 6.17.1 Lupin Pharmaceuticals Company Information
  99. 6.17.2 Lupin Pharmaceuticals Business Overview
  100. 6.17.3 Lupin Pharmaceuticals Hypertension Medications Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Lupin Pharmaceuticals Hypertension Medications Product Portfolio
  102. 6.17.5 Lupin Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Hypertension Medications Market Size (2021-2032)
  2. 7.2 North America Hypertension Medications Market Size by Type
  3. 7.2.1 North America Hypertension Medications Market Size by Type (2021-2026)
  4. 7.2.2 North America Hypertension Medications Market Size by Type (2027-2032)
  5. 7.2.3 North America Hypertension Medications Market Share by Type (2021-2032)
  6. 7.3 North America Hypertension Medications Market Size by Application
  7. 7.3.1 North America Hypertension Medications Market Size by Application (2021-2026)
  8. 7.3.2 North America Hypertension Medications Market Size by Application (2027-2032)
  9. 7.3.3 North America Hypertension Medications Market Share by Application (2021-2032)
  10. 7.4 North America Hypertension Medications Market Size by Country
  11. 7.4.1 North America Hypertension Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Hypertension Medications Market Size by Country (2021-2026)
  13. 7.4.3 North America Hypertension Medications Market Size by Country (2027-2032)
  14. 7.4.4 North America Hypertension Medications Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Hypertension Medications Market Size (2021-2032)
  2. 8.2 Europe Hypertension Medications Market Size by Type
  3. 8.2.1 Europe Hypertension Medications Market Size by Type (2021-2026)
  4. 8.2.2 Europe Hypertension Medications Market Size by Type (2027-2032)
  5. 8.2.3 Europe Hypertension Medications Market Share by Type (2021-2032)
  6. 8.3 Europe Hypertension Medications Market Size by Application
  7. 8.3.1 Europe Hypertension Medications Market Size by Application (2021-2026)
  8. 8.3.2 Europe Hypertension Medications Market Size by Application (2027-2032)
  9. 8.3.3 Europe Hypertension Medications Market Share by Application (2021-2032)
  10. 8.4 Europe Hypertension Medications Market Size by Country
  11. 8.4.1 Europe Hypertension Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Hypertension Medications Market Size by Country (2021-2026)
  13. 8.4.3 Europe Hypertension Medications Market Size by Country (2027-2032)
  14. 8.4.4 Europe Hypertension Medications Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Hypertension Medications Market Size (2021-2032)
  2. 9.2 China Hypertension Medications Market Size by Type
  3. 9.2.1 China Hypertension Medications Market Size by Type (2021-2026)
  4. 9.2.2 China Hypertension Medications Market Size by Type (2027-2032)
  5. 9.2.3 China Hypertension Medications Market Share by Type (2021-2032)
  6. 9.3 China Hypertension Medications Market Size by Application
  7. 9.3.1 China Hypertension Medications Market Size by Application (2021-2026)
  8. 9.3.2 China Hypertension Medications Market Size by Application (2027-2032)
  9. 9.3.3 China Hypertension Medications Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Hypertension Medications Market Size (2021-2032)
  2. 10.2 Asia Hypertension Medications Market Size by Type
  3. 10.2.1 Asia Hypertension Medications Market Size by Type (2021-2026)
  4. 10.2.2 Asia Hypertension Medications Market Size by Type (2027-2032)
  5. 10.2.3 Asia Hypertension Medications Market Share by Type (2021-2032)
  6. 10.3 Asia Hypertension Medications Market Size by Application
  7. 10.3.1 Asia Hypertension Medications Market Size by Application (2021-2026)
  8. 10.3.2 Asia Hypertension Medications Market Size by Application (2027-2032)
  9. 10.3.3 Asia Hypertension Medications Market Share by Application (2021-2032)
  10. 10.4 Asia Hypertension Medications Market Size by Country
  11. 10.4.1 Asia Hypertension Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Hypertension Medications Market Size by Country (2021-2026)
  13. 10.4.3 Asia Hypertension Medications Market Size by Country (2027-2032)
  14. 10.4.4 Asia Hypertension Medications Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Hypertension Medications Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Hypertension Medications Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Hypertension Medications Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Hypertension Medications Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Hypertension Medications Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Hypertension Medications Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Hypertension Medications Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Hypertension Medications Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Hypertension Medications Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Hypertension Medications Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Hypertension Medications Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Hypertension Medications Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Hypertension Medications Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Hypertension Medications Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst